These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2850585)

  • 1. Chronic SCH 23390 produces tolerance to morphine extrapyramidal effects.
    De Montis MG; Devoto P; Saba P; Porcella A; Meloni D; Tagliamonte A
    Pharmacol Res Commun; 1988 Dec; 20(12):1115-6. PubMed ID: 2850585
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphine-6-glucuronide and morphine: mu-opioid receptor binding and effects on dopamine-sensitive adenylate cyclase in striatum.
    Christensen CB; Mørk A; Geisler A
    Pharmacol Toxicol; 1991 Nov; 69(5):396-8. PubMed ID: 1666432
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
    O'Shaughnessy CT; Headley PM
    Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interactive effects of D1 and D2 dopamine receptor blockade.
    Salama AI; Saller CF
    Adv Exp Med Biol; 1986; 204():137-50. PubMed ID: 2947425
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats.
    Onali P; Olianas MC; Gessa GL
    Eur J Pharmacol; 1984 Mar; 99(1):127-8. PubMed ID: 6233165
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine-sensitive adenylate cyclase of the caudate nucleus of rats treated with morphine.
    Clouet DH; Iwatsubo K
    Life Sci; 1975 Jul; 17(1):35-40. PubMed ID: 238090
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in the striatal adenylate cyclase activity following acute and chronic morphine treatment and during withdrawal.
    Puri SK; Volicer L; Cochin J
    J Neurochem; 1976 Dec; 27(6):1551-4. PubMed ID: 1033988
    [No Abstract]   [Full Text] [Related]  

  • 8. Adaptive changes in the number of Gs- and Gi-proteins underlie adenylyl cyclase sensitization in morphine-treated rat striatal neurons.
    Van Vliet BJ; Van Rijswijk AL; Wardeh G; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1993 Mar; 245(1):23-9. PubMed ID: 8386668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of morphine sulfate on adenylate cyclase and phosphodiesterase activities in rat corpus striatum.
    Puri SK; Cochin J; Volicer L
    Life Sci; 1975 Mar; 16(5):759-67. PubMed ID: 164598
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.
    Hess EJ; Creese I
    Adv Exp Med Biol; 1986; 204():29-52. PubMed ID: 2878579
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance to extrapyramidal effects of opiates in rats chronically treated with SCH 23390.
    De Montis GM; Devoto P; Meloni D; Porcella A; Saba P; Tagliamonte A
    J Neurosci Res; 1989 Oct; 24(2):286-92. PubMed ID: 2531233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of morphine of prostaglandin E2 (PGE2)-sensitive adenylate cyclase in corpus striatum of rats and its cellular localization by using kainic acid.
    Havemann U; Kuschinsky K
    Brain Res; 1978 Jul; 150(2):441-5. PubMed ID: 209852
    [No Abstract]   [Full Text] [Related]  

  • 13. mu-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure.
    Van Vliet BJ; De Vries TJ; Wardeh G; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1991 Oct; 208(2):105-11. PubMed ID: 1666051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine D1 receptor: biochemical and behavioral aspects.
    Andersen PH; Nielsen EB
    Adv Exp Med Biol; 1986; 204():73-91. PubMed ID: 2878580
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential effects of chronic agonist administration on mu-opioid receptor- and muscarinic receptor-regulated adenylate cyclase in rat striatal neurons.
    Van Vliet BJ; Dotman CH; Wardeh G; Mulder AH; Schoffelmeer AN
    Life Sci; 1992; 51(10):PL89-94. PubMed ID: 1325016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic electroconvulsive shock on D1 and D2 dopamine receptor-mediated activity of adenylate cyclase in homogenates of striatum and limbic forebrain of rat.
    Newman ME; Lerer B
    Neuropharmacology; 1989 Aug; 28(8):787-90. PubMed ID: 2674765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different dopamine stimulation of adenylate cyclase in striatum and mesolimbic area of rats treated with chronic chlorpromazine.
    Kaneno S; Watanabe S; Toru M; Shimazono Y
    Brain Res; 1978 Aug; 152(2):396-400. PubMed ID: 679034
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclic AMP efflux from rat striatal slices is enhanced by CCK.
    O'Shaughnessy C; Poat JA; Turnbull MJ
    Biochem Pharmacol; 1987 Mar; 36(6):976-9. PubMed ID: 3032201
    [No Abstract]   [Full Text] [Related]  

  • 20. Genotype-dependent sensitivity to morphine: dopamine involvement in morphine-induced running in the mouse.
    Trabucchi M; Spano PF; Racagni G; Oliverio A
    Brain Res; 1976 Sep; 114(3):536-40. PubMed ID: 182326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.